Concepedia
Statistics
Publications
14
Citations
4.6K
H-Index
13
Active since
1999
Affiliations
University of Edinburgh(Current)
The Queen's Medical Research Institute
University of Glasgow
Queen's Medical Centre
NHS Highland
David P. Macfarlane is an author at University of Edinburgh specializing in endocrinology, metabolic regulation, and medicine.
Publications per year
1999–2021
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 3K citations · Full text
Medicine, Endocrinology, Pharmacology +14
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 629 citations · Full text
Medicine, Endocrinology, Nephrology +15
Glucocorticoids and fatty acid metabolism in humans: fuelling fat redistribution in the metabolic syndrome
David P. Macfarlane, Shareen Forbes, Brian R. Walker · Journal of Endocrinology · 2008 · 384 citations · Full text
Life Sciences, Biochemistry, Endocrinology +17
One-Hour Plasma Glucose Identifies Insulin Resistance and β-Cell Dysfunction in Individuals With Normal Glucose Tolerance
Melania Manco, Simona Panunzi, David P. Macfarlane et al. · Diabetes Care · 2010 · 103 citations · Full text
Medicine, Endocrinology, Diabetology +16
5α-Reductase Type 1 Deficiency or Inhibition Predisposes to Insulin Resistance, Hepatic Steatosis, and Liver Fibrosis in Rodents
Dawn E. W. Livingstone, Pascal Barat, Emma M. Di Rollo et al. · Diabetes · 2014 · 98 citations · Full text
Medicine, Endocrinology, Pharmacology +17
1–5 of 14